WORLD
Amgen's Battle with Sanofi and Regeneron at the U.S. Supreme Court over Its Cholesterol ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Amgen’s battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha has some drugmakers hoping a ruling will reshape U.S. patent law and competition among companies that make antibody medicines ...'
Amgen’s battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha has some drugmakers hoping a ruling will reshape U.S. patent law and competition among companies that make antibody medicines https://t.co/7dMprGZ5R5— Reuters (@Reuters) March 28, 2023
(The above story first appeared on LatestLY on Mar 28, 2023 07:57 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
